Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 09/23 10:00:00 pm
13.52 USD   -0.81%
09/15 ARIAD PHARMACEU : Announces Ponatinib Data Presentations at European..
08/30 ARIAD PHARMACEU : Completes Rolling Submission of New Drug Applicati..
08/29 ARIAD PHARMACEU : to Present at the Morgan Stanley Global Healthcare..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ARIAD PHARMACEUTICALS, INC
11/02/16 Q3 2016 Earnings Release (Projected)
02/28/17 FY 2016 Earnings Release (Projected)
05/10/17 Q1 2017 Earnings Release (Projected)
08/09/17 Interim 2017 Earnings Release (Projected)
Past events on ARIAD PHARMACEUTICALS, INC
09/12/16 | 08:50pm Morgan Stanley Global Health Care Conference
07/28/16 | 02:30pm Interim 2016 Earnings Call
07/28/16 | 01:35pm Interim 2016 Earnings Release
07/21/16 | 04:00pm Annual General Meeting
Upcoming sector events for ARIAD PHARMACEUTICALS, INC
09/26/16 | 08:00pm ALKERMES PLC : Analyst and Investor Meeting
09/28/16 | 07:35pm ALNYLAM PHARMACEUTICALS, INC. : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
09/28/16 | 09:40pm VERTEX PHARMACEUTICALS INCORPORATED : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
09/29/16 | 07:00pm TESARO INC : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
Annual publications
Previous yearNext Year
Annual results2012201320142015 (e)2016 (e)
Sales
Million $
Released
Forecast
Spread
0,56
0,92
-39%
45,6
43,6
4,4%
105
77,8
36%

123

189
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-197
-199
1,0%
-269
-281
4,0%
-151
-166
8,9%
-205
-208
1,8%

-110
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-205
-204
-0,54%
-274
-286
4,2%
-160
-183
12%
-217
-223
2,4%

-120
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-221

-274







Net income
Million $
Released
Forecast
Spread
-221
-218
-1,5%
-274
-286
4,1%
-163
-183
11%

-236

-58,5
EPS
 $
Released
Forecast
Spread
-1,34
-1,32
-1,3%
-1,49
-1,56
4,3%
-0,87
-0,97
9,9%
-1,23
-1,26
2,6%

-0,31
Announcement Date02/25/201302/25/201402/19/201511/30/-0001

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2015
Q1
2016
Q2
2016
Q3
2016 (e)
Q4
2016 (e)
Sales
Million $
Released
Forecast
Spread

41,4
35,6
43,3
-18%
68,1
60,6
12%

39,8

46,4
Operating income (EBITDA)
Million $
Released
Forecast
Spread

-63,2





-32,0

-32,0
Operating profit (EBIT)
Million $
Released
Forecast
Spread

-58,6
-44,9
-43,9
-2,3%
-11,7
-13,4
13%

-32,8

-27,3
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread

-65,1
-53,8
-45,4
-18%
110
-23,1
576%

-38,6

-32,2
EPS
 $
Released
Forecast
Spread

-0,34
-0,28
-0,24
-17%
0,56
-0,12
573%

-0,20

-0,17
Announcement Date05/10/201607/28/2016

© 2016 Thomson Reuters
© 2016 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise